Postdoctoral Position in Multiplexed Single-Cell RNAseq-Based Antibody Discovery (LBMM)
École polytechnique fédérale de Lausanne (EPFL) – Laboratory of Biomedical Microfluidics · Switzerland
Deadline
Open until filled
Degree Level
Postdoctoral
Funding
Fully Funded
Location
On-site
Overview
Postdoc in Prof. Christoph Merten's lab using highly multiplexed single-cell transcriptomics to discover new therapeutic antibodies. Target start is 1 October 2026 and the advert is still accepting applications (cover letter, CV, research statement and three referees in one PDF).
Eligibility
PhD with hands-on single-cell analysis and/or antibody discovery experience; 10X Genomics or DropSeq workflows; flow cytometry; cell biology/biochemistry background; microfluidics a plus.
Nationality: Open to all nationalities
Funding & Benefits
Fixed-term (1 year, renewable) salaried EPFL postdoc; salary not stated in advert.
